WuXi Biologics (Cayman) (FRA:1FW2) 3-Year EBITDA Growth Rate : 60.90% (As of Jun. 2023)

View and export this data going back to 2017. Start your Free Trial

What is WuXi Biologics (Cayman) 3-Year EBITDA Growth Rate?

WuXi Biologics (Cayman)'s EBITDA per Share for the six months ended in Jun. 2023 was €0.08.

During the past 12 months, WuXi Biologics (Cayman)'s average EBITDA Per Share Growth Rate was -3.00% per year. During the past 3 years, the average EBITDA Per Share Growth Rate was 60.90% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was 63.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 10 years, the highest 3-Year average EBITDA Per Share Growth Rate of WuXi Biologics (Cayman) was 79.40% per year. The lowest was 57.80% per year. And the median was 62.95% per year.

Competitive Comparison of WuXi Biologics (Cayman)'s 3-Year EBITDA Growth Rate

For the Biotechnology subindustry, WuXi Biologics (Cayman)'s 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

WuXi Biologics (Cayman)'s 3-Year EBITDA Growth Rate Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, WuXi Biologics (Cayman)'s 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where WuXi Biologics (Cayman)'s 3-Year EBITDA Growth Rate falls into.

WuXi Biologics (Cayman) 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

WuXi Biologics (Cayman) (FRA:1FW2) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

WuXi Biologics (Cayman) 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of WuXi Biologics (Cayman)'s 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

WuXi Biologics (Cayman) (FRA:1FW2) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » WuXi Biologics (Cayman) Inc (FRA:1FW2) » Definitions » 3-Year EBITDA Growth Rate

Comparable Companies

Traded in Other Exchanges

WXIBF:USA WXXWY:USA 2269:Mexico 02269:Hong Kong 1FW1:Germany

Address

No. 108, Meiliang Road, Mashan Binhu District, Wuxi, CHN, 214092

Website

https://www.wuxibiologics.com

WuXi Biologics is one of the largest global biologics CRDMOs. WuXi Biologics, incorporated in 2014 following the reorganization of WuXi PharmaTech, later known as WuXi AppTec, now has global revenue of CNY 15 billion. North American represented 55.6% of total revenue in 2022. It adopts the follow and win the molecule strategy by providing end-to-end services, from drug discovery to commercial manufacturing. It also adopts a global dual-sourcing strategy by providing drug products and large-scale drug substance manufacturing.

WuXi Biologics (Cayman) (FRA:1FW2) Headlines

No Headlines